Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: Report from an international pilot study

Journal of Medical Systems

Volumn 26, Issue 4, 2002, Pages 293-300

  Buell, Hope E ^a   Stables, Rodney H ^b   DeLong, Elizabeth R ^a   Shuping, Kathy B ^a   Killip, Donna M ^c   Lever, Harry M ^d   McKenna, William J ^e   Rubin, David ^d   Sigwart, Ulrich ^b   Takayama, Morimasa ^f   Wagner, Galen S ^a   Eisenstein, Eric L ^a,g   Spencer III, William H ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hypertrophic obstructive cardiomyopathy; Internet computing; Medical registry; Percutaneous transluminal septal reduction

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ANALYSIS; DATA BASE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERNET; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT INFORMATION; PATIENT REGISTRY; PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION; PERCUTANEOUS TRANSLUMINAL SEPTAL REDUCTION; TREATMENT OUTCOME; CATHETER ABLATION; CLINICAL TRIAL; COMPARATIVE STUDY; DEVELOPED COUNTRY; HEART VENTRICLE SEPTUM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PILOT STUDY; REGISTER; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; DEVELOPED COUNTRIES; FEMALE; HEART SEPTUM; HUMANS; INTERNET; MALE; MIDDLE AGED; PILOT PROJECTS; REGISTRIES;

EID: 12144290279     PISSN: 01485598     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015812603042     Document Type: Article

References (23)

1. Maron, B. J., Gardin., J. M., Flack, J. M., Gidding, S. S., Kurosaki, T. T., and Bild, D. E., Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 92(4):785-789, 1995.
2. Robbins, R. C. and Stinson, E. B., Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 111(3):586-594, 1996.
3. McCully, R. B., Nishimura, R. A., Tajik, A. J., Schaff, H. V., and Danielson, G. K., Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 94(3):467-471, 1996.
4. Nishimura, R. A., Hayes, D. L., Ilstrup, D. M., Holmes, D. R., Jr., and Tajik, A. J., Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: Acute Doppler echocardiographic and catheterization hemodynamic study. J. Am. Coll. Cardiol. 27(2):421-430, 1996.
5. Betochhi, S., Losi, M. A., Piscione, F., Boccalatte, M., Pace, L., Golino, P., Perrone-Filardi, P., Briguori, C., Franculli, F., Pappone, C., Salvatore, M., and Chiariello, M., Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and diastolic function. Am. J. Cardiol. 77(7):498-502, 1996.
6. Nishimura, R. A., Trusty, J. M., Hayes, D. L., Ilstrup, D. M., Larson, D. R., Hayes, S. N., Allison, T. G., and Tajik, A. J., Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover study. J. Am. Coll. Cardiol. 29(2):435-441, 1997.
7. Sigwart, U., Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet 346(8969):211-214, 1995.
8. Spirito, P., and Maron, B. J., Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy. J. Am. Coll. Cardiol. 33(4):1071-1075, 1999.
9. Gietzen, F., Leuner, C., Gerenkamp, T., and Kuhn, H., Transcoronary ablation of septal hypertrophy: A new catheter interventional therapy of hypertrophic obstructive cardiomyopathy [abstract]. Circulation 94(8, Suppl. I):1-84, 1996.
10. Faber, L., Seggewiss, H., and Gleichmann, U., Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography. Circulation 98(22):2415-2421, 1998.
11. Knight, C. J., Kurbaan, A. S., Seggewiss, H., Henein, M., Gunning, M., Harrington, D., Fassbender, D., Gleichmann, U., and Sigwart, U., Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 95(8):2075-2081, 1997.
12. Seggewiss, H., Gleichman, U., Faber, L., Fassbender, D., Schmidt, H., and Strick, S., Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopath: Acute results and 3-month follow-up in 25 patients. J. Am. Coll. Cardiol. 31:252-258, 1998.
13. Kuhn, H., Gietzen, F., Leuner, C. H., and Gerenkamp, T., Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur. Heart. J. 18(5):846-851, 1997.
14. Lakkis, N. M., Nagueh, S. F. Kleiman, N. S., Killip, D., He, Z. X., Verani, M. S., Roberts, R., and Spencer, W. H., III. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 98(17):1750-1755, 1998.
15. Brock, R., Functional obstruction of the left ventricle (acquired aortic subvalvular stenosis). Guy's Hops Rep. 106:221-238, 1957.
16. Teare D., Assymmetrical hypertrophy of the heart in young adults. Br. Heart J. 20:1-8, 1958.
17. Shah, P. M., Adelman, A. G., Wigle, E. D., Gobel, F. L., Burchell, H. B., Hardarson, T., Curiel, R., De La Calzada, C., Oakley, C. M., and Goodwill, J. F., The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ. Res. 35(Suppl. II): II-179-II-195, 1974.
18. Frank, S., and Braunwald, E., Idiopathic hypertrophic subaortic stenosis: Clinical analysis of 126 patients with emphasis on the natural history. Circulation 37(5):759-788, 1968.
19. Hardarson, T., De La Calzada, C. S., Curiel, R., and Goodwin, J. F., Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 2(7844):1462-1467, 1973.
20. Adelman, A. G., Wigle, E. D. Ranganathan, N., Webb, G. D., Kidd, B. S. L., Bigelow, W. G., and Silver M. D., The clinical course in muscular subaortic stenosis: A retrospective and prospective study of 60 hemodynamically proved cases. Ann. Intern. Med. 77(4):515-525, 1972.
21. Tavel, M. E., and Petrin, T. E., Hypertrophic subaortic stenosis in the "real world." Chest 77(6):715-718, 1980.
22. Petrin, T. J., and Tavel, M. E., Idiopathic hypertrophic subaortic stenosis as observed in a large community hospital: Relation to age and history of hypertension. J. Am. Geriatr. Soc. 27(1):43-46, 1979.
23. Lever, H. M., Karam, R. F., Currie, P. J., and Healy, B. P., Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation 79(3):580-589, 1989.